Tacrolimus-induced optic neuropathy: A case report

Intrduction. Tacrolimus (fujimycin or FK506) is a potent immunosuppressive drug with growing usage. It is usually used in prevention of transplanted organ rejection. Its use is highly valuable, but like other immunosupressants, it has adverse effects. One of them is optic neuropathy. Cas...

Full description

Bibliographic Details
Main Authors: Žorić Lepša, Ilić Aleksandra, Čolak Emina, Mirković Miloš, Pantelić Jelica, Mirić Dijana, Kisić Bojana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2022-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502100004Z.pdf
_version_ 1818161414490030080
author Žorić Lepša
Ilić Aleksandra
Čolak Emina
Mirković Miloš
Pantelić Jelica
Mirić Dijana
Kisić Bojana
author_facet Žorić Lepša
Ilić Aleksandra
Čolak Emina
Mirković Miloš
Pantelić Jelica
Mirić Dijana
Kisić Bojana
author_sort Žorić Lepša
collection DOAJ
description Intrduction. Tacrolimus (fujimycin or FK506) is a potent immunosuppressive drug with growing usage. It is usually used in prevention of transplanted organ rejection. Its use is highly valuable, but like other immunosupressants, it has adverse effects. One of them is optic neuropathy. Case report. A 47-year-old white male patients who had received tacrolimus therapy for nine years, after kidney transplantation, developed a subacute, painless vision loss on both eyes. He was thoroughly examined on different possible optic neuropathies and other causes of vision loss. After exclusion of other possible causes, the diagnosis of toxic optic neuropathy was established. His therapy was converted to cyclosporine, by his nephrologist, but his vision had improved only slightly. Conclusion. Toxic optic neuropathies are presented in everyday ophthalmological practice, but they are underestimated. Diagnosis can be demanding, especially when it comes to drugs and substances whose possible toxic effect on the optic nerve is not widely known. Unlike other adverse effects of tacrolimus therapy on nervous system, optic neuropathy can causes great and permanent functional impairment.
first_indexed 2024-12-11T16:17:24Z
format Article
id doaj.art-a0a088237d9c4f639c06fcd3b79e4e49
institution Directory Open Access Journal
issn 0042-8450
2406-0720
language English
last_indexed 2024-12-11T16:17:24Z
publishDate 2022-01-01
publisher Military Health Department, Ministry of Defance, Serbia
record_format Article
series Vojnosanitetski Pregled
spelling doaj.art-a0a088237d9c4f639c06fcd3b79e4e492022-12-22T00:58:56ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502406-07202022-01-0179661962310.2298/VSP201126004Z0042-84502100004ZTacrolimus-induced optic neuropathy: A case reportŽorić Lepša0Ilić Aleksandra1Čolak Emina2Mirković Miloš3Pantelić Jelica4Mirić Dijana5Kisić Bojana6https://orcid.org/0000-0002-3018-1186University of Priština, Faculty of Medicine, Ophthalmology Department, Kosovska Mitrovica, Serbia + University Clinical Center of Serbia, Institute of Eye Diseases, Belgrade, SerbiaUniversity Clinical Center of Serbia, Institute of Eye Diseases, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, SerbiaUniversity Clinical Center of Serbia, Institute of Medical Biochemistry, Belgrade, SerbiaUniversity of Priština, Faculty of Medicine, Ophthalmology Department, Kosovska Mitrovica, SerbiaUniversity Clinical Center of Serbia, Institute of Eye Diseases, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, SerbiaUniversity of Priština, Faculty of Medicine, Institute of Medical Biochemistry, Kosovska Mitrovica, SerbiaUniversity of Priština, Faculty of Medicine, Institute of Medical Biochemistry, Kosovska Mitrovica, SerbiaIntrduction. Tacrolimus (fujimycin or FK506) is a potent immunosuppressive drug with growing usage. It is usually used in prevention of transplanted organ rejection. Its use is highly valuable, but like other immunosupressants, it has adverse effects. One of them is optic neuropathy. Case report. A 47-year-old white male patients who had received tacrolimus therapy for nine years, after kidney transplantation, developed a subacute, painless vision loss on both eyes. He was thoroughly examined on different possible optic neuropathies and other causes of vision loss. After exclusion of other possible causes, the diagnosis of toxic optic neuropathy was established. His therapy was converted to cyclosporine, by his nephrologist, but his vision had improved only slightly. Conclusion. Toxic optic neuropathies are presented in everyday ophthalmological practice, but they are underestimated. Diagnosis can be demanding, especially when it comes to drugs and substances whose possible toxic effect on the optic nerve is not widely known. Unlike other adverse effects of tacrolimus therapy on nervous system, optic neuropathy can causes great and permanent functional impairment.http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502100004Z.pdfdrug-related side effects and adverse reactionstacrolimustoxic optic neuropathytreatment outcome
spellingShingle Žorić Lepša
Ilić Aleksandra
Čolak Emina
Mirković Miloš
Pantelić Jelica
Mirić Dijana
Kisić Bojana
Tacrolimus-induced optic neuropathy: A case report
Vojnosanitetski Pregled
drug-related side effects and adverse reactions
tacrolimus
toxic optic neuropathy
treatment outcome
title Tacrolimus-induced optic neuropathy: A case report
title_full Tacrolimus-induced optic neuropathy: A case report
title_fullStr Tacrolimus-induced optic neuropathy: A case report
title_full_unstemmed Tacrolimus-induced optic neuropathy: A case report
title_short Tacrolimus-induced optic neuropathy: A case report
title_sort tacrolimus induced optic neuropathy a case report
topic drug-related side effects and adverse reactions
tacrolimus
toxic optic neuropathy
treatment outcome
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502100004Z.pdf
work_keys_str_mv AT zoriclepsa tacrolimusinducedopticneuropathyacasereport
AT ilicaleksandra tacrolimusinducedopticneuropathyacasereport
AT colakemina tacrolimusinducedopticneuropathyacasereport
AT mirkovicmilos tacrolimusinducedopticneuropathyacasereport
AT pantelicjelica tacrolimusinducedopticneuropathyacasereport
AT miricdijana tacrolimusinducedopticneuropathyacasereport
AT kisicbojana tacrolimusinducedopticneuropathyacasereport